Existing clinical biomarkers, including myocardial necrosis (cardiac troponin I, cTnI), stress (B-type natriuretic peptide, BNP), and inflammation (high-sensitivity C-reactive protein, hs-CRP), are insufficient for precise HF prediction in patients with AMI5. Here, TNNI3 is linked to hydrops fetalis.